Oxidative stress is a widespread phenomenon in the pathology of neurodegene
rative diseases such as Alzheimer's disease, Parkinson's disease, and amyot
rophic lateral sclerosis. Neuronal cell death due to oxidative stress may c
ausally contribute to the pathogeneses of these diseases. Therefore, neurop
rotective antioxidants are considered to be a promising approach to slow do
wn disease progression. We have investigated different aromatic amine and i
mine compounds for neuroprotective antioxidant functions in cell culture, a
nd found that these compounds possess excellent cytoprotective potential in
diverse paradigms of oxidative neuronal cell death, including clonal cell
lines, primary cerebellar neurons, and organotypic hippocampal slice cultur
es. Aromatic amines and imines are effective against oxidative glutamate to
xicity, glutathione depletion, and hydrogen peroxide toxicity. Their mode o
f action as direct antioxidants; was experimentally confirmed by electron s
pin resonance spectroscopy, cell-free brain lipid peroxidation assays, and
intracellular peroxide measurements. With half-maximal effective concentrat
ions of 20-75 nm in different neuroprotection experiments, the aromatic imi
nes phenothiazine, phenoxazine, and iminostilbene proved to be about two or
ders of magnitude more effective than common phenolic antioxidants. This re
markable efficacy could be directly correlated to calculated properties of
the compounds by means of a novel, quantitative structure-activity relation
ship model. We conclude that bridged bisarylimines with a single free NH-bo
nd, such as iminostilbene, are superior neuroprotective antioxidants, and m
ay be promising lead structures for rational drug development.